ATAI
AtaiBeckley | Creating breakthroughs in mental health
Berlin, Germany · Founded 2018 · $65.4M raised
- Headquarters
- Berlin
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- atai.life
- Total Funding
- $65.4M
- Last Round
- $43.0M Series BMar 2019
- Rounds
- 3
About
Clinical-stage biopharmaceutical company developing psychedelic-based treatments for mental health disorders.
Summary
ATAI is a Biotech company based in Berlin, Germany, founded in 2018. It has raised $65.4M in total across 3 rounds, most recently a $43.0M Series B round in Mar 2019. Investors include Subversive Capital, Peter Thiel and Christian Angermayer.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2019
Sign up to see all 3 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/atai"><img src="https://indexed.vc/api/badge/company/atai" alt="ATAI on Indexed.vc" width="260" height="76" /></a>